Enjoy complimentary customisation on priority with our Enterprise License!
The retinal drugs market size is forecast to increase by USD 8.40 billion at a CAGR of 6.78% between 2023 and 2028. The market is experiencing significant growth due to the rising prevalence of retinal diseases, particularly age-related macular degeneration (AMD) and diabetic retinopathy. According to the World Health Organization, AMD is the leading cause of vision loss in adults over 50 years old, and diabetic retinopathy affects approximately 285 million people worldwide. The development of innovative therapies, such as gene therapies and anti-VEGF agents, offers new treatment options for these debilitating conditions. However, the high cost associated with retinal disease therapy remains a major challenge for patients and healthcare systems, limiting widespread access to these advanced treatments. Despite this, the market is expected to continue growing due to the increasing demand for effective treatments and the potential for new technological advancements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Indication
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.